Using IDO1 Inhibitors To Combat Cancer
Companies developing the small-molecule drugs hope to expose cancer cells to the immune system
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
April 6, 2015 Cover
Volume 93, Issue 14
Companies developing the small-molecule drugs hope to expose cancer cells to the immune system
Cover image:
Credit:
Companies developing the small-molecule drugs hope to expose cancer cells to the immune system
Snapshots from the American Chemical Society national meeting
ACS Meeting News: From sewage sludge to junkyards, scientists explore new ways to mine metals
Rural setting for event is a new approach for the chemical giant
Even with no evidence of health risk, calls for labeling, better study increase
The fungal toxin cytochalasin B reduces skin cell size and could find its way into skin creams